Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection

WNV is a zoonotic neurotropic flavivirus that has recently emerged globally as a significant cause of viral encephalitis. The last five years, 624 incidents of WNV infection have been reported in Greece. The risk for severe WNV disease increases among immunosuppressed individuals implying thus the c...

Full description

Bibliographic Details
Main Authors: Sarri, Constantina A., Markantoni, Maria, Stamatis, Costas, Papa, Anna, Tsakris, Athanasios, Pervanidou, Danai, Baka, Agoritsa, Politis, Constantina, Billinis, Charalambos, Hadjichristodoulou, Christos, Mamuris, Zissis
Format: Online
Language:English
Published: Public Library of Science 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094746/
id pubmed-5094746
recordtype oai_dc
spelling pubmed-50947462016-11-18 Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection Sarri, Constantina A. Markantoni, Maria Stamatis, Costas Papa, Anna Tsakris, Athanasios Pervanidou, Danai Baka, Agoritsa Politis, Constantina Billinis, Charalambos Hadjichristodoulou, Christos Mamuris, Zissis Research Article WNV is a zoonotic neurotropic flavivirus that has recently emerged globally as a significant cause of viral encephalitis. The last five years, 624 incidents of WNV infection have been reported in Greece. The risk for severe WNV disease increases among immunosuppressed individuals implying thus the contribution of the MHC locus to the control of WNV infection. In order to investigate a possible association of MHC class II genes, especially HLA-DPA1, HLA-DQA1, HLA-DRB1, we examined 105 WNV patients, including 68 cases with neuroinvasive disease and 37 cases with mild clinical phenotype, collected during the period from 2010 to2013, and 100 control individuals selected form the Greek population. Typing was performed for exon 2 for all three genes. DQA1*01:01 was considered to be "protective" against WNV infection (25.4% vs 40.1%, P = 0.004) while DQA1*01:02 was associated with increased susceptibility (48.0% vs 32.1%, P = 0.003). Protection against neuroinvasion was associated with the presence of DRB1*11:02 (4.99% vs 0.0%, P = 0.018). DRB1*16:02 was also absent from the control cohort (P = 0.016). Three additional population control groups were used in order to validate our results. No statistically significant association with the disease was found for HLA-DPA alleles. The results of the present study provide some evidence that MHC class II is involved in the response to WNV infection, outlining infection "susceptibility" and "CNS-high-risk" candidates. Furthermore, three new alleles were identified while the frequency of all alleles in the study was compared with worldwide data. The characterization of the MHC locus could help to estimate the risk for severe WNV cases in a country. Public Library of Science 2016-11-03 /pmc/articles/PMC5094746/ /pubmed/27812212 http://dx.doi.org/10.1371/journal.pone.0165952 Text en © 2016 Sarri et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Sarri, Constantina A.
Markantoni, Maria
Stamatis, Costas
Papa, Anna
Tsakris, Athanasios
Pervanidou, Danai
Baka, Agoritsa
Politis, Constantina
Billinis, Charalambos
Hadjichristodoulou, Christos
Mamuris, Zissis
spellingShingle Sarri, Constantina A.
Markantoni, Maria
Stamatis, Costas
Papa, Anna
Tsakris, Athanasios
Pervanidou, Danai
Baka, Agoritsa
Politis, Constantina
Billinis, Charalambos
Hadjichristodoulou, Christos
Mamuris, Zissis
Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
author_facet Sarri, Constantina A.
Markantoni, Maria
Stamatis, Costas
Papa, Anna
Tsakris, Athanasios
Pervanidou, Danai
Baka, Agoritsa
Politis, Constantina
Billinis, Charalambos
Hadjichristodoulou, Christos
Mamuris, Zissis
author_sort Sarri, Constantina A.
title Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
title_short Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
title_full Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
title_fullStr Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
title_full_unstemmed Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection
title_sort genetic contribution of mhc class ii genes in susceptibility to west nile virus infection
description WNV is a zoonotic neurotropic flavivirus that has recently emerged globally as a significant cause of viral encephalitis. The last five years, 624 incidents of WNV infection have been reported in Greece. The risk for severe WNV disease increases among immunosuppressed individuals implying thus the contribution of the MHC locus to the control of WNV infection. In order to investigate a possible association of MHC class II genes, especially HLA-DPA1, HLA-DQA1, HLA-DRB1, we examined 105 WNV patients, including 68 cases with neuroinvasive disease and 37 cases with mild clinical phenotype, collected during the period from 2010 to2013, and 100 control individuals selected form the Greek population. Typing was performed for exon 2 for all three genes. DQA1*01:01 was considered to be "protective" against WNV infection (25.4% vs 40.1%, P = 0.004) while DQA1*01:02 was associated with increased susceptibility (48.0% vs 32.1%, P = 0.003). Protection against neuroinvasion was associated with the presence of DRB1*11:02 (4.99% vs 0.0%, P = 0.018). DRB1*16:02 was also absent from the control cohort (P = 0.016). Three additional population control groups were used in order to validate our results. No statistically significant association with the disease was found for HLA-DPA alleles. The results of the present study provide some evidence that MHC class II is involved in the response to WNV infection, outlining infection "susceptibility" and "CNS-high-risk" candidates. Furthermore, three new alleles were identified while the frequency of all alleles in the study was compared with worldwide data. The characterization of the MHC locus could help to estimate the risk for severe WNV cases in a country.
publisher Public Library of Science
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094746/
_version_ 1613712288757317632